GENEVA, Oct. 9 -- OMMA THERAPEUTICS, INC. filed a patent application (US2026/022240) for “MULTICYCLIC COMPOUNDS AND USE THEREOF TO TREAT INFLAMMATION, EDEMA AND THROMBOSIS”. With publication no. WO/2026/213512, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07D 401/12

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....